Rate this post

Mochi Health vs Maximus: Compare GLP-1 Programs & Pricing

Side-by-side Mochi Health and Maximus: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.

Mochi Health and Maximus are two established telehealth providers offering GLP-1–based weight‑management programs. This article compares Mochi Health vs Maximus to help you identify which best fits your goals and preferences.

Visit Mochi Health
Explore Maximus

Mochi Health vs Maximus: Quick Overview

Provider	Semaglutide	Tirzepatide	Promo	Membership
Mochi Health	$99.00	$199.00	No long-term commitment (Code: )	$79.99 — Yes
Maximus		$132.99	(Code: )	— No

Mochi Health vs Maximus: Medical Process & Accessibility

Mochi Health focuses on a rapid telehealth intake, a concise health questionnaire, and clinician approval within 24‑48 hours. After approval, a licensed pharmacy compounds the GLP‑1 medication and ships it directly to your door. Maximus uses a slightly longer onboarding process that includes a virtual consult, baseline labs (if needed), and a structured follow‑up schedule that can extend over several months.

Start with Mochi Health

Mochi Health vs Maximus: Pricing Comparison

Mochi Health starts semaglutide at $99.00 and tirzepatide at $199.00. Maximus currently lists tirzepatide at $132.99 and does not publish a semaglutide price on its public page. Because the tirzepatide price at Maximus is lower than Mochi’s $199.00, it is highlighted in bold for quick reference.

Both programs require a monthly medication fee plus any applicable membership charge. Mochi Health adds a $79.99 monthly membership fee, which unlocks discounted medication pricing and access to a private support portal. Maximus does not require a membership, so the medication cost is the only recurring charge.

Compare Maximus Pricing

Mochi Health vs Maximus: Clinical Oversight & Support

Each provider employs board‑certified physicians, nurse practitioners, or physician assistants who are authorized to prescribe GLP‑1 therapies. Mochi Health’s model is built for speed—once your questionnaire is reviewed, a prescription can be issued within one business day. Maximus, on the other hand, assigns each patient a dedicated care coordinator who monitors progress, adjusts dosages, and schedules quarterly virtual check‑ins.

Book a Consultation with Mochi Health

Mochi Health vs Maximus: Medication Quality & Safety

Both companies source compounded GLP‑1 medications from FDA‑registered compounding pharmacies in the United States. While the products are not branded Wegovy® or Mounjaro®, they contain the same active ingredients (semaglutide or tirzepatide) and must meet strict USP standards for potency, sterility, and labeling. Prescriptions are written by licensed clinicians, and the pharmacies operate under FDA oversight for compounded drugs.

Mochi Health vs Maximus: Insurance & Shipping

Neither Mochi Health nor Maximus currently accept traditional health‑insurance benefits for the medication itself; they operate on a cash‑pay model. Shipping is free for the first order with both providers, and subsequent shipments are typically delivered via standard ground service within 3‑7 business days. Some states may have restrictions on telehealth prescribing of GLP‑1 drugs; both platforms verify state eligibility during the intake process.

Explore Maximus Shipping Details

Mochi Health vs Maximus: Customer Experience

Online reviews indicate that Mochi Health users appreciate the low upfront cost and the ability to start treatment quickly. The platform’s mobile‑first design makes it easy to upload documents and track shipments. Maximus reviewers often highlight the personalized coaching, regular dose‑titration guidance, and the sense of having a “medical team” behind their weight‑loss journey.

Read Mochi Health Reviews

Mochi Health vs Maximus: Eligibility & Contraindications

Both programs require you to be 18 years or older, have a BMI of at least 27 kg/m² (or a physician‑documented weight‑related condition), and pass a basic medical safety screen. Contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, or severe gastrointestinal disease. A telehealth clinician will verify eligibility before any prescription is written, ensuring FDA‑compliant safety standards.

Check Maximus Eligibility

Mochi Health vs Maximus: Final Verdict

Choose Mochi Health if you prioritize a lower medication price for tirzepatide, a quick start‑up timeline, and are comfortable managing your own follow‑up care. Opt for Maximus if you value ongoing clinical oversight, no mandatory membership fee, and a structured dose‑optimization plan. Both providers meet FDA telehealth prescribing guidelines and partner with accredited pharmacies, making them safe and legally compliant options for GLP‑1 therapy.

Join Mochi Health
Get Started with Maximus

Disclaimer

This article is for informational purposes only and does not constitute medical advice. ExploreProviders may receive affiliate commissions at no cost to you. Always consult a licensed clinician before beginning any medical treatment.

⭐ Editor’s Choice